Alexandria Co. For Pharmaceuticals & Chemical Industries Share Price
Stocks
AXPH
EGS38341C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
14/09/2026
|
5-day change | 1st Jan Change | ||
| 1,664.97 EGP | -0.22% |
|
-2.25% | +108.03% |
| Market Cap | 5.6B 108M 93.8M 88.52M 80.3M 151M 10.38B 152M 1.06B 407M 5.26B 407M 398M 16.73B | P/E 2024 |
4.86x | P/E 2025 | 5.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.31B 103M 89.07M 84.06M 76.26M 143M 9.85B 144M 1B 387M 5B 386M 378M 15.89B | EV / Sales 2024 |
0.51x | EV / Sales 2025 | 0.71x |
| Free-Float |
17.74% | Yield 2024 |
14.2% | Yield 2025 | 14.1% |
| 1 day | -0.22% | ||
| 1 week | -2.25% | ||
| Current month | -2.23% | ||
| 1 month | +27.54% | ||
| 3 months | +48.77% | ||
| 6 months | +109.26% | ||
| Current year | +108.03% |
| 1 week | 1,653.21 |  | 1,699.99 |
| 1 month | 1,315.01 | | 1,768 |
| Current year | 701.66 | | 1,768 |
| 1 year | 651 | | 1,768 |
| 3 years | 120 | | 1,768 |
| 5 years | 85 | | 1,768 |
| 10 years | 46 | | 1,768 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Ahmed Fuad
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | -2.25% | +136.20% | +1,035.80% | 161M | |
| +2.02% | -0.96% | +50.69% | +92.40% | 1,015B | |
| +0.28% | -3.24% | +49.57% | +62.65% | 642B | |
| +1.81% | +2.07% | +19.89% | +70.38% | 463B | |
| -1.15% | +2.08% | +37.40% | +36.90% | 353B | |
| -0.39% | +1.59% | +16.30% | +23.11% | 265B | |
| -0.72% | +1.79% | +5.91% | +10.49% | 254B | |
| +1.10% | -12.75% | +38.03% | +45.44% | 206B | |
| -0.45% | -4.47% | -21.44% | -58.15% | 191B | |
| +1.87% | -3.04% | +27.81% | +89.26% | 182B | |
| Average | +0.31% | -3.14% | +36.04% | +140.83% | 357.04B | |
| Weighted average by Cap. | +0.43% | -2.21% | +33.69% | +56.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.77B 34.2M 29.64M 27.97M 25.37M 47.6M 3.28B 47.95M 334M 129M 1.66B 128M 126M 5.29B | 2.75B 53.21M 46.11M 43.51M 39.47M 74.05M 5.1B 74.59M 520M 200M 2.59B 200M 195M 8.23B |
| Net income | 217M 4.19M 3.63M 3.43M 3.11M 5.83M 402M 5.88M 40.94M 15.77M 204M 15.74M 15.4M 648M | 391M 7.57M 6.56M 6.19M 5.61M 10.53M 725M 10.61M 73.9M 28.48M 368M 28.42M 27.8M 1.17B |
| Net Debt | -149M -2.89M -2.5M -2.36M -2.14M -4.02M -277M -4.05M -28.19M -10.86M -140M -10.84M -10.6M -446M | -282M -5.45M -4.72M -4.46M -4.04M -7.58M -522M -7.64M -53.23M -20.51M -265M -20.47M -20.02M -842M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | EGP 1,664.97 | -0.22% | 1,583 |
| 13/09/26 | EGP 1,668.70 | -0.59% | 2,022 |
| 10/09/26 | EGP 1,678.57 | +0.91% | 3,415 |
| 09/09/26 | EGP 1,663.45 | -1.35% | 2,807 |
| 08/09/26 | EGP 1,686.15 | -1.01% | 1,996 |
- Stock Market
- Stocks
- AXPH Stock
Select your edition
All financial news and data tailored to specific country editions
